top of page

Our Mission

EFEVRE TECH combines an agile amalgamation of scientific experts towards a common goal.

WHO.png

Who We Are

​

Embracing a multifaceted Research and Development approach EFEVRE TECH focuses in the design, manufacture and retail of prototypes and innovative devices in the fields of Health science, Biology, environment management and alternative energy around the globe. Always having in mind customer needs and necessities!

Who We Are

MISSION.png

Our Mission​

​

EFEVRE TECH LTD's mission is to provide innovative software solutions and advance R&D in Health Science, Biology, Environment, and Alternative Energy, creating cutting-edge prototypes and devices that cater to global customer needs while inspiring collaboration and progress. 

Our Mission

VISION.png

Our Vision​

​

EFEVRE TECH LTD envisions itself as a global leader in research and innovation, fostering strategic partnerships to develop ground-breaking products. Our commitment to a multifaced R&D approach, customer-centric solutions, and worldwide impact will drive progress and inspire a sustainable future. 

Our Vision

Our Journey

Timeline.png
1
2
3
4
5
6
7
8
9
10
11
12
13
14
June 2018
EFEVRE TECH LTD is established as a company
November 2018
First Grant Approval as an Innovative Enterprise in Cyprus from the Ministry of Commerce
May 2019
European Grant Award for AMGEL Basic Device
May 2020
AMGEL Basic Device Prototype was completed and pilot tested at the University of Cyprus
December 2020
First Order of the AMGEL Basic Device at Agricultural Research Institute of Cyprus in an open tender
2022
Grand Fundings from the Cyprus Research and Innovation Center for new Automation Products
2023
Grand Fundings from the Cyprus Research and Innovation Center for five vouchers as collaborators for other companies
December 2023
AMGEL 247 Pro Prototype was completed and launch to the market
February 2024
Secured and Received an Investment for the development costs of the new AMGEL 4TT Device
December 2024
Launch of the new AMGEL 4TT Device in the field of Molecular Diagnostics 
2024
ISO Certifications Secured for ISO 9001:2015 and ISO 14001:2015
2024
Collaboration with 50 leading scientific institutions in the EU through the establishment of the LIFESPIRIT Community
2024
European Patent Approved in 26 countries for AMGEL Technology, including Germany, England and France
January 2025
First Order of AMGEL 4TT Device delivery at the University of Cambridge in the Automation of New Molecular Diagnostic Methods

Stay Connected!

  • LinkedIn
  • Facebook
  • Twitter

© All Rights Reserved 2035

bottom of page